About: Island Pharmaceuticals Limited, a drug repurposing company, focuses on the development of antiviral therapeutics for infectious diseases in Australia and the United States. The company's lead product candidate is ISLA-101, a drug which is in second clinical-stage for the prevention and treatment of dengue fever and other mosquito vector borne diseases; and Galidesivir, a spectrum antiviral candidate with the potential to address multiple high-priority RNA virus threats. Island Pharmaceuticals Limited was founded in 2017 and is based in Hawthorn East, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.40 (-1.23%)
ILA ASX Island Pharmaceuticals Ltd
Island Pharmaceuticals Ltd share price
ILA price activity
Last Price
$0.400
Change (24hr)
-0.01 AUD (-1.23%)
Volume
264.52K
Volume (4w avg)
-
Open
$0.41
Day Range
$0.40 - $0.41
Previous Close
$0.41
Last Trade
25 Sep, 5:44 am GMT+0
Delayed
25 Sep, 5:44 am GMT+0
ILA price performance
Delayed
25 Sep, 5:44 am GMT+0
ILA Market Signals